CVS has agreed to pay £28.3 million ($37.76 million) and admitted responsibility after a decade of billing government health programmes for far more insulin than diabetic patients actually needed. The ...
Auto stocks are in the spotlight today, with the Nifty Auto index climbing nearly 3% in the intra-day trading session. The brokerage house Nuvama expects healthy wholesale growth across passenger ...
Eli Lilly’s stock closed at a record high after the drugmaker disclosed that one of the nation’s most powerful pharmacy-benefit managers will start covering its popular GLP-1 medications later this ...
Leaders detailed real-world neffy use data, stating approximately "90% of patients experiencing anaphylaxis are effectively treated with just a single dose, consistent with published results for ...
More than 500 drivers and warehouse workers at the CVS distribution center in Fredericksburg, Va. have authorized a strike via the Teamsters Union Local 592. The DC serves the Washington, D.C. and ...
Diabetes hardware company embecta aims to look beyond insulin and reshape itself into a more varied drug delivery provider—and it’s kick-starting that effort with the acquisition of a global ...
Embecta, a company that develops diabetes management solutions, is moving into the auto-injection market with its latest planned acquisition. The Becton Dickinson & CO spinoff reported it would ...
While GLP-1 weight loss meds have been a mainstay in pop culture for a few years now, they're potentially about to get even more widespread. Formerly only available as an injection, Wegovy recently ...
Eli Lilly on Monday launched a new form of its blockbuster obesity drug, Zepbound, that offers a month's worth of doses in a single pen. The pen could serve as a more convenient option for some ...
Many people living with rheumatoid arthritis (RA) rely on long-term medications to manage joint pain, stiffness, and inflammation. A number of these treatments are given as subcutaneous injections, ...
Google began stuffing Gemini into its dominant Chrome browser several months ago, and today the AI is expanding its capabilities considerably. Google says the chatbot will be easier to access and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results